Global Epilepsy Therapeutics Market Research Report 2023

Report ID: 1898140 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Epilepsy Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Anti-epileptic Drugs
        1.2.3 Dietary Supplements
        1.2.4 Vagal Nerve Stimulation
        1.2.5 Surgical Therapies
    1.3 Market by Application
        1.3.1 Global Epilepsy Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Neurology Centers
        1.3.4 Home Care Settings
        1.3.5 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Epilepsy Therapeutics Market Perspective (2017-2028)
    2.2 Epilepsy Therapeutics Growth Trends by Region
        2.2.1 Epilepsy Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Epilepsy Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Epilepsy Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Epilepsy Therapeutics Market Dynamics
        2.3.1 Epilepsy Therapeutics Industry Trends
        2.3.2 Epilepsy Therapeutics Market Drivers
        2.3.3 Epilepsy Therapeutics Market Challenges
        2.3.4 Epilepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Epilepsy Therapeutics Players by Revenue
        3.1.1 Global Top Epilepsy Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Epilepsy Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Epilepsy Therapeutics Revenue
    3.4 Global Epilepsy Therapeutics Market Concentration Ratio
        3.4.1 Global Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Therapeutics Revenue in 2021
    3.5 Epilepsy Therapeutics Key Players Head office and Area Served
    3.6 Key Players Epilepsy Therapeutics Product Solution and Service
    3.7 Date of Enter into Epilepsy Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Epilepsy Therapeutics Breakdown Data by Type
    4.1 Global Epilepsy Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Epilepsy Therapeutics Forecasted Market Size by Type (2023-2028)
5 Epilepsy Therapeutics Breakdown Data by Application
    5.1 Global Epilepsy Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Epilepsy Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Epilepsy Therapeutics Market Size (2017-2028)
    6.2 North America Epilepsy Therapeutics Market Size by Country (2017-2022)
    6.3 North America Epilepsy Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Epilepsy Therapeutics Market Size (2017-2028)
    7.2 Europe Epilepsy Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Epilepsy Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Epilepsy Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Epilepsy Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Epilepsy Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Epilepsy Therapeutics Market Size (2017-2028)
    9.2 Latin America Epilepsy Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Epilepsy Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Epilepsy Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Epilepsy Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Epilepsy Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Epilepsy Therapeutics Introduction
        11.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Cephalon
        11.2.1 Cephalon Company Detail
        11.2.2 Cephalon Business Overview
        11.2.3 Cephalon Epilepsy Therapeutics Introduction
        11.2.4 Cephalon Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.2.5 Cephalon Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Epilepsy Therapeutics Introduction
        11.3.4 Novartis Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Epilepsy Therapeutics Introduction
        11.4.4 Pfizer Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Epilepsy Therapeutics Introduction
        11.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Detail
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Epilepsy Therapeutics Introduction
        11.6.4 GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Detail
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Epilepsy Therapeutics Introduction
        11.7.4 Sanofi Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.7.5 Sanofi Recent Development
    11.8 Sunovion Pharmaceuticals
        11.8.1 Sunovion Pharmaceuticals Company Detail
        11.8.2 Sunovion Pharmaceuticals Business Overview
        11.8.3 Sunovion Pharmaceuticals Epilepsy Therapeutics Introduction
        11.8.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.8.5 Sunovion Pharmaceuticals Recent Development
    11.9 Bausch Health
        11.9.1 Bausch Health Company Detail
        11.9.2 Bausch Health Business Overview
        11.9.3 Bausch Health Epilepsy Therapeutics Introduction
        11.9.4 Bausch Health Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.9.5 Bausch Health Recent Development
    11.10 Takeda
        11.10.1 Takeda Company Detail
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Epilepsy Therapeutics Introduction
        11.10.4 Takeda Revenue in Epilepsy Therapeutics Business (2017-2022)
        11.10.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Epilepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Anti-epileptic Drugs
    Table 3. Key Players of Dietary Supplements
    Table 4. Key Players of Vagal Nerve Stimulation
    Table 5. Key Players of Surgical Therapies
    Table 6. Global Epilepsy Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Epilepsy Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Epilepsy Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Epilepsy Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Epilepsy Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Epilepsy Therapeutics Market Share by Region (2023-2028)
    Table 12. Epilepsy Therapeutics Market Trends
    Table 13. Epilepsy Therapeutics Market Drivers
    Table 14. Epilepsy Therapeutics Market Challenges
    Table 15. Epilepsy Therapeutics Market Restraints
    Table 16. Global Epilepsy Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Epilepsy Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Therapeutics as of 2021)
    Table 19. Ranking of Global Top Epilepsy Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Epilepsy Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Epilepsy Therapeutics Product Solution and Service
    Table 23. Date of Enter into Epilepsy Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Epilepsy Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Epilepsy Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Epilepsy Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Epilepsy Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Epilepsy Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Epilepsy Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Epilepsy Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Epilepsy Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Epilepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Epilepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Epilepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Epilepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Epilepsy Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Epilepsy Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Epilepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Epilepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Epilepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Epilepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Abbott Laboratories Company Detail
    Table 44. Abbott Laboratories Business Overview
    Table 45. Abbott Laboratories Epilepsy Therapeutics Product
    Table 46. Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Abbott Laboratories Recent Development
    Table 48. Cephalon Company Detail
    Table 49. Cephalon Business Overview
    Table 50. Cephalon Epilepsy Therapeutics Product
    Table 51. Cephalon Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Cephalon Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Epilepsy Therapeutics Product
    Table 56. Novartis Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Pfizer Company Detail
    Table 59. Pfizer Business Overview
    Table 60. Pfizer Epilepsy Therapeutics Product
    Table 61. Pfizer Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. Pfizer Recent Development
    Table 63. Johnson & Johnson Company Detail
    Table 64. Johnson & Johnson Business Overview
    Table 65. Johnson & Johnson Epilepsy Therapeutics Product
    Table 66. Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Johnson & Johnson Recent Development
    Table 68. GlaxoSmithKline Company Detail
    Table 69. GlaxoSmithKline Business Overview
    Table 70. GlaxoSmithKline Epilepsy Therapeutics Product
    Table 71. GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. GlaxoSmithKline Recent Development
    Table 73. Sanofi Company Detail
    Table 74. Sanofi Business Overview
    Table 75. Sanofi Epilepsy Therapeutics Product
    Table 76. Sanofi Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 77. Sanofi Recent Development
    Table 78. Sunovion Pharmaceuticals Company Detail
    Table 79. Sunovion Pharmaceuticals Business Overview
    Table 80. Sunovion Pharmaceuticals Epilepsy Therapeutics Product
    Table 81. Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. Sunovion Pharmaceuticals Recent Development
    Table 83. Bausch Health Company Detail
    Table 84. Bausch Health Business Overview
    Table 85. Bausch Health Epilepsy Therapeutics Product
    Table 86. Bausch Health Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 87. Bausch Health Recent Development
    Table 88. Takeda Company Detail
    Table 89. Takeda Business Overview
    Table 90. Takeda Epilepsy Therapeutics Product
    Table 91. Takeda Revenue in Epilepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 92. Takeda Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epilepsy Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Anti-epileptic Drugs Features
    Figure 3. Dietary Supplements Features
    Figure 4. Vagal Nerve Stimulation Features
    Figure 5. Surgical Therapies Features
    Figure 6. Global Epilepsy Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Neurology Centers Case Studies
    Figure 9. Home Care Settings Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Epilepsy Therapeutics Report Years Considered
    Figure 12. Global Epilepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Epilepsy Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Epilepsy Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Epilepsy Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Epilepsy Therapeutics Revenue in 2021
    Figure 18. North America Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Epilepsy Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Epilepsy Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Epilepsy Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Epilepsy Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Epilepsy Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Epilepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 47. Cephalon Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 49. Pfizer Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 52. Sanofi Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 53. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 54. Bausch Health Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 55. Takeda Revenue Growth Rate in Epilepsy Therapeutics Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Cephalon
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Sanofi
Sunovion Pharmaceuticals
Bausch Health
Takeda
Frequently Asked Questions
Epilepsy Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Epilepsy Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Epilepsy Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Epoxy Grout

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

E-prescribing

E-prescribing market is segmented by players, region (country), by Type and by Application. Playe ... Read More

Ether Carboxylates

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More